Loading clinical trials...
Loading clinical trials...
To determine if MRD (minimal residual disease) can be found in the blood (only) as opposed to bone marrow in children with ALL (acute lymphoblastic leukemia).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Stanford University
NCT04940468 · Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Acute, and more
NCT00907517 · Myelogenous Leukemia, Acute, Leukemia, Lymphocytic, Acute, and more
NCT00246662 · Leukemia, Lymphocytic, Acute, Leukemia, Nonlymphocytic, Acute, and more
NCT00185523 · Leukemia, Lymphocytic, Acute, Leukemia, and more
NCT00125840 · Solid Tumors, Leukemia, Lymphocytic, Acute, Pediatric, and more
Stanford University School of Medicine
Stanford, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions